Historically, sickle cell anaemia has been widely neglected within its global epicentre of sub-Saharan Africa. More than ...

The new gene therapies for sickle cell disease—including the gene-editing treatment Casgevy, based on research at Boston ...

The hospital faces challenges of blood shortages, space constraints, and community awareness gaps in managing sickle cell ...

Dear Dr. Roach: I read your recent column on shingles. I am 66 years old and in fairly good health. I had both Shingrix shots ...

The revenue for Povorcitinib is expected to reach an annual total of $91 mn by 2035 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to ...

Children who received a stem cell transplant for sickle cell disease (SCD) experienced better quality of life outcomes and cognitive perfo ...

I have a serious problem with my fingernails splitting and coming off at the edges. I have tried biotin and keratin for almost a year without results.

I read your recent column on shingles. I am 66 years old and in fairly good health. I had both Shingrix shots about five years ago. I ...

Fedratinib can reduce symptoms and spleen volume in patients with myelodysplastic syndrome (MDS) or myeloproliferative neoplasms (MPNs), according to research presented at the ASH Annual Meeting 2024.

SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in ...

INCY's phase III study, evaluating retifanlimab in combination with platinum-based chemotherapy for the treatment of metastatic non-small cell lung cancer, meets primary and secondary endpoints.

I read your recent column on shingles. I am 66 and in fairly good health. I had both Shingrix shots about five years ago. I take hydroxyurea for polycythemia vera (PV). Around Aug.